MEP12008A - Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives - Google Patents

Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives

Info

Publication number
MEP12008A
MEP12008A MEP-120/08A MEP12008A MEP12008A ME P12008 A MEP12008 A ME P12008A ME P12008 A MEP12008 A ME P12008A ME P12008 A MEP12008 A ME P12008A
Authority
ME
Montenegro
Prior art keywords
derivatives
production
pharmaceutical preparations
preparations containing
novel morpholine
Prior art date
Application number
MEP-120/08A
Other languages
Bosnian (bs)
English (en)
Inventor
Jean Philippe Ducoux
Xavier Emonds-Alt
Patrick Gueule
Vincenzo Proietto
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of MEP12008A publication Critical patent/MEP12008A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/30—1,4-Oxazines; Hydrogenated 1,4-oxazines not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MEP-120/08A 1999-03-25 2000-03-21 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives MEP12008A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903854A FR2791346B3 (fr) 1999-03-25 1999-03-25 Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR2000/000695 WO2000058292A1 (fr) 1999-03-25 2000-03-21 Nouveaux derives de morpholine, procede pour leur preparation et compositions pharmaceutiques les contenant

Publications (1)

Publication Number Publication Date
MEP12008A true MEP12008A (en) 2010-06-10

Family

ID=9543720

Family Applications (2)

Application Number Title Priority Date Filing Date
MEP-2008-120A ME00057B (me) 1999-03-25 2000-03-21 Novi derivati morfolina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže
MEP-120/08A MEP12008A (en) 1999-03-25 2000-03-21 Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MEP-2008-120A ME00057B (me) 1999-03-25 2000-03-21 Novi derivati morfolina, postupak za njihovo dobijanje i farmaceutske kompozicije koje ih sadrže

Country Status (41)

Country Link
US (1) US6506750B1 (xx)
EP (1) EP1165528B1 (xx)
JP (1) JP3853155B2 (xx)
KR (1) KR100696340B1 (xx)
CN (1) CN100422160C (xx)
AR (1) AR023139A1 (xx)
AT (1) ATE275136T1 (xx)
AU (1) AU756855B2 (xx)
BG (1) BG64623B1 (xx)
BR (1) BR0009281B1 (xx)
CA (1) CA2366829C (xx)
CO (1) CO5160340A1 (xx)
CZ (1) CZ300911B6 (xx)
DE (1) DE60013418T2 (xx)
DK (1) DK1165528T3 (xx)
EE (1) EE04525B1 (xx)
ES (1) ES2226794T3 (xx)
FR (1) FR2791346B3 (xx)
HK (1) HK1042092B (xx)
HR (1) HRP20010704B1 (xx)
HU (1) HUP0201863A3 (xx)
ID (1) ID29871A (xx)
IL (2) IL145041A0 (xx)
IS (1) IS2338B (xx)
ME (2) ME00057B (xx)
MX (1) MXPA01009643A (xx)
NO (1) NO321576B1 (xx)
NZ (1) NZ513674A (xx)
PE (1) PE20001596A1 (xx)
PL (1) PL205318B1 (xx)
PT (1) PT1165528E (xx)
RS (1) RS50085B (xx)
RU (1) RU2222537C2 (xx)
SI (1) SI1165528T1 (xx)
SK (1) SK286977B6 (xx)
TR (1) TR200102639T2 (xx)
TW (1) TW534906B (xx)
UA (1) UA73931C2 (xx)
UY (1) UY26079A1 (xx)
WO (1) WO2000058292A1 (xx)
ZA (1) ZA200106981B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6943160B2 (en) * 2000-11-28 2005-09-13 Smithkline Beecham Plc Morpholine derivatives as antagonists of orexin receptors
FR2824828B1 (fr) * 2001-05-21 2005-05-20 Sanofi Synthelabo Nouveaux derives de piperidinecarboxamide, un procede pour leur preparation et les compositions pharmaceutiques les contenant
GB0228787D0 (en) * 2002-12-10 2003-01-15 Pfizer Ltd Morpholine dopamine agonists
JP2006511555A (ja) * 2002-12-13 2006-04-06 スミスクライン ビーチャム コーポレーション Ｃｃｒ５拮抗剤としての複素環式化合物
JO2485B1 (en) * 2002-12-23 2009-01-20 شركة جانسين فارماسوتيكا ان. في 1-Piperidine-3-Yl-4-Piperidine-4-Yl-Piperazine derivatives substituted and used as quinine antagonists
CN1897942A (zh) * 2003-12-22 2007-01-17 先灵公司 药用组合物
FR2873373B1 (fr) * 2004-07-23 2006-09-08 Sanofi Synthelabo Derives de 4-arylmorpholin-3-one, leur preparation et leur application en therapeutique
CN103142569B (zh) * 2013-02-27 2016-01-20 南京医科大学 2,6-二异丙基苯甲酸及其衍生物作为神经保护剂的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ3134U1 (cs) * 1995-01-10 1995-03-17 Pavel Ing. Janda Rotor universálního radiálního ventilátoru
FR2729954B1 (fr) 1995-01-30 1997-08-01 Sanofi Sa Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
US5780466A (en) * 1995-01-30 1998-07-14 Sanofi Substituted heterocyclic compounds method of preparing them and pharmaceutical compositions in which they are present
RU2135494C1 (ru) * 1995-12-01 1999-08-27 Санкио Компани Лимитед Гетероциклические соединения и композиция на их основе, проявляющая антагонистическое действие в отношении рецепторов тахикинина
JP3192631B2 (ja) * 1997-05-28 2001-07-30 三共株式会社 飽和複素環化合物からなる医薬
PT1048658E (pt) 1997-12-04 2005-10-31 Sankyo Co Derivados heterociclicos acilados aliciclicos

Also Published As

Publication number Publication date
PL351317A1 (en) 2003-04-07
CA2366829A1 (fr) 2000-10-05
FR2791346B3 (fr) 2001-04-27
FR2791346A1 (fr) 2000-09-29
UY26079A1 (es) 2000-10-31
HRP20010704B1 (en) 2005-04-30
IS2338B (is) 2008-02-15
PT1165528E (pt) 2005-01-31
JP2002540195A (ja) 2002-11-26
UA73931C2 (en) 2005-10-17
TR200102639T2 (tr) 2002-02-21
DE60013418T2 (de) 2005-09-22
CN1353698A (zh) 2002-06-12
EE200100499A (et) 2002-12-16
PL205318B1 (pl) 2010-04-30
YU68201A (sh) 2004-03-12
CZ300911B6 (cs) 2009-09-09
ME00057B (me) 2010-10-10
BR0009281A (pt) 2002-01-22
PE20001596A1 (es) 2001-04-01
KR100696340B1 (ko) 2007-03-20
ES2226794T3 (es) 2005-04-01
TW534906B (en) 2003-06-01
HRP20010704A2 (en) 2002-08-31
NO321576B1 (no) 2006-06-06
EE04525B1 (et) 2005-08-15
SI1165528T1 (en) 2005-02-28
ID29871A (id) 2001-10-18
IS6063A (is) 2001-08-24
AU756855B2 (en) 2003-01-23
CA2366829C (fr) 2007-05-15
CO5160340A1 (es) 2002-05-30
MXPA01009643A (es) 2002-05-14
WO2000058292A1 (fr) 2000-10-05
HUP0201863A3 (en) 2003-03-28
AU3301600A (en) 2000-10-16
HUP0201863A2 (hu) 2002-12-28
IL145041A0 (en) 2002-06-30
EP1165528A1 (fr) 2002-01-02
ZA200106981B (en) 2002-10-24
BG64623B1 (bg) 2005-09-30
HK1042092B (zh) 2005-04-22
CZ20013365A3 (cs) 2002-01-16
DE60013418D1 (de) 2004-10-07
BR0009281B1 (pt) 2011-05-17
NZ513674A (en) 2003-05-30
ATE275136T1 (de) 2004-09-15
RU2222537C2 (ru) 2004-01-27
BG105923A (en) 2002-05-31
HK1042092A1 (en) 2002-08-02
NO20014632D0 (no) 2001-09-24
CN100422160C (zh) 2008-10-01
SK286977B6 (sk) 2009-08-06
SK13462001A3 (sk) 2002-05-09
JP3853155B2 (ja) 2006-12-06
RS50085B (sr) 2009-01-22
DK1165528T3 (da) 2005-01-10
IL145041A (en) 2010-11-30
NO20014632L (no) 2001-11-26
AR023139A1 (es) 2002-09-04
KR20010108381A (ko) 2001-12-07
EP1165528B1 (fr) 2004-09-01
US6506750B1 (en) 2003-01-14

Similar Documents

Publication Publication Date Title
AR014261A1 (es) Compuestos hipolipidemicos de benzotiazepina, composiciones y proceso para su preparacion
RU94038064A (ru) Производные пиперазина и пиперидина, их применение в качестве противопсихотических средств, способ их получения фармацевтическая композиция
EA200301306A1 (ru) Производные 1-фенилсульфонил-1,3-дигидро-2h-индол-2-она, их получение и их терапевтическое применение
MEP45308A (en) [1,8]naphthyridin-2-ones and related compounds for the treatment of schizophrenia
BR0108395A (pt) Derivados de pirrolopirimidinona, processos de preparação e uso
BRPI0409109A (pt) novos compostos
AR035792A1 (es) Compuestos de n-(4-quinazolinil)-n-(1h-indazol-5-il) amina, inhibidor de la rho-quinasa, su uso para la fabricacion de un medicamento y metodo para prepararlo
NL194914B (nl) 4H-1-benzopyran-4-onderivaat of zout daarvan, en farmaceutisch preparaat dat dit als actieve stof bevat.
YU56995A (sh) Soli derivata indola
SE9904738D0 (sv) Novel compounds
MEP51408A (en) Selected cgrp antagonists, method for production and use thereof as medicament
FI946073A0 (fi) Vitamiini D-sarjan, 20-asemassa modifioituja johdannaisia, menetelmä tällaisten johdannaisten valmistamiseksi, menetelmässä käytettäviä välituotteita, mainittuja johdannaisia sisältäviä farmaseuttisia valmisteita ja johdannaisten käyttö lääkeaineiden valmistamiseen
FR2670491B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les renfermant.
MEP9309A (en) Novel oligosaccharides, preparation method and pharmaceutical compositions containing the same
TW200508207A (en) New benzimidazole derivatives
MEP12008A (en) Novel morpholine derivatives, method for the production thereof and pharmaceutical preparations containing said derivatives
ZA806399B (en) New 2-hydroxyalkyl-3,4,5-trihydroxypiperidine compounds, their production and their medicinal use
PT82512A (fr) Procede de preparation de derives de quinolylglycinamides ayant activite psychotrope et de compositions pharmaceutiques les contenant
MEP11908A (en) (1-phenacy-3-phenyl-3-piperidylethyl) piperidine derivatives, method for the production thereof and pharmaceutical compositions containing the same
EA200400806A1 (ru) Способ получения эхинокандиновых соединений
FR2767527B1 (fr) Derives de piperazines indoliques, utiles comme medicaments et procede de preparation
HRP20050815A2 (en) 2-(butyl-1-sulfonylamino)-n-[1(r)-(6-methoxy-pyridin-3-yl)-propyl]-benzamid, the use thereof in the form of drug an pharmaceutical preparations containing said compound
FR2804958B1 (fr) Derives de xanthine, leur procede de preparation et les intermediaires de ce procede, leur application comme medicament et les compositions pharmaceutiques les renfermant
YU78695A (sh) Derivati piperazina, lekovi koji sadrže dva jedinjenja, njihova primena i postupci za njihovo pripremanje
EA200200610A1 (ru) НОВЫЕ ЗАМЕЩЕННЫЕ ПИРАЗОЛО [4,3-е]ДИАЗЕПИНЫ, ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ, СОДЕРЖАЩИЕ ИХ, ПРИМЕНЕНИЕ В КАЧЕСТВЕ ЛЕКАРСТВЕННЫХ ПРОДУКТОВ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ